RPID Key Statistics, Chart & Performance
The current stock price of RPID is 3.75 USD. In the past month the price increased by 19.81%. In the past year, price increased by 7.76%.
RPID Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to RPID. When comparing the yearly performance of all stocks, RPID is a bad performer in the overall market: 69.1% of all stocks are doing better.
RPID Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to RPID. RPID has a bad profitability rating. Also its financial health evaluation is rather negative.
RPID Financial Highlights
Over the last trailing twelve months RPID reported a non-GAAP Earnings per Share(EPS) of -1.01. The EPS increased by 9.82% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -52.47% | ||
| ROE | -99.91% | ||
| Debt/Equity | 0.43 |
RPID Forecast & Estimates
10 analysts have analysed RPID and the average price target is 8.16 USD. This implies a price increase of 117.6% is expected in the next year compared to the current price of 3.75.
For the next year, analysts expect an EPS growth of 6.03% and a revenue growth 19.19% for RPID
RPID Ownership
RPID Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 22.03 | 205.423B | ||
| DHR | DANAHER CORP | 25.51 | 153.038B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 150.09 | 49.868B | ||
| A | AGILENT TECHNOLOGIES INC | 21.06 | 36.146B | ||
| IQV | IQVIA HOLDINGS INC | 14.73 | 32.812B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 29.87 | 28.211B | ||
| WAT | WATERS CORP | 22.68 | 19.534B | ||
| ILMN | ILLUMINA INC | 22.65 | 17.916B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 31.71 | 17.908B | ||
| MEDP | MEDPACE HOLDINGS INC | 31.55 | 14.94B |
Related stock screener links
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About RPID
Company Profile
Rapid Micro Biosystems, Inc. is a life sciences technology company. The company is headquartered in Lexington, Massachusetts and currently employs 163 full-time employees. The company went IPO on 2021-07-15. Its flagship Growth Direct system automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in pharmaceutical manufacturing operations. The company offers four specific applications for testing of microbial contamination: Environmental Monitoring, which tests the manufacturing environment, including circulating air, exposed surfaces, and personnel; Water, which tests any purified water used at any stage of the drug production process, including water for injection; In-Process Bioburden, which tests raw materials, drug substance and in-process product, and Sterility Release offering final testing of finished product to ensure sterility before the product is released for commercial sale.
Company Info
RAPID MICRO BIOSYSTEMS INC-A
25 Hartwell Avenue
Lexington MASSACHUSETTS US
CEO: Robert Spignesi
Employees: 163
Phone: 19783493200
RAPID MICRO BIOSYSTEMS INC-A / RPID FAQ
Can you describe the business of RAPID MICRO BIOSYSTEMS INC-A?
Rapid Micro Biosystems, Inc. is a life sciences technology company. The company is headquartered in Lexington, Massachusetts and currently employs 163 full-time employees. The company went IPO on 2021-07-15. Its flagship Growth Direct system automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in pharmaceutical manufacturing operations. The company offers four specific applications for testing of microbial contamination: Environmental Monitoring, which tests the manufacturing environment, including circulating air, exposed surfaces, and personnel; Water, which tests any purified water used at any stage of the drug production process, including water for injection; In-Process Bioburden, which tests raw materials, drug substance and in-process product, and Sterility Release offering final testing of finished product to ensure sterility before the product is released for commercial sale.
Can you provide the latest stock price for RAPID MICRO BIOSYSTEMS INC-A?
The current stock price of RPID is 3.75 USD. The price decreased by -3.1% in the last trading session.
What is the dividend status of RAPID MICRO BIOSYSTEMS INC-A?
RPID does not pay a dividend.
What is the ChartMill technical and fundamental rating of RPID stock?
RPID has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What is the analyst forecast for RPID stock?
10 analysts have analysed RPID and the average price target is 8.16 USD. This implies a price increase of 117.6% is expected in the next year compared to the current price of 3.75.
Is RAPID MICRO BIOSYSTEMS INC-A (RPID) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on RPID.
Can you provide the ownership details for RPID stock?
You can find the ownership structure of RAPID MICRO BIOSYSTEMS INC-A (RPID) on the Ownership tab.